MyFinsight
Home
Blog
About
Proceeds from issuance of
common stock
$12,000K
(149900.00%↑ Y/Y)
Proceeds from issuance of
pre-funded warrants
$3,000K
Proceeds from issuance of
common stock from atm...
$31K
(-96.80%↓ Y/Y)
Maturity of investments
$1,500K
(-88.32%↓ Y/Y)
Proceeds from sale of
fixed assets
$42K
Net cash provided by
financing activities
$15,031K
(41.27%↑ Y/Y)
Net cash provided by
(used in) investing...
$1,542K
(239.04%↑ Y/Y)
Net increase
(decrease) in cash and cash...
$7,097K
(451.86%↑ Y/Y)
Canceled cashflow
$9,476K
Stock-based compensation
expense
$1,101K
(-36.14%↓ Y/Y)
Depreciation
$14K
(-51.72%↓ Y/Y)
Net cash used in
operating activities
-$9,476K
(17.94%↑ Y/Y)
Canceled cashflow
$1,115K
Change in the fair value
of warrant...
-$6,700K
(-277.04%↓ Y/Y)
Net loss
-$2,676K
(75.67%↑ Y/Y)
Change in the fair value
of promissory note
-$500K
(-18.20%↓ Y/Y)
Prepaid expenses, other
current and non-current...
$337K
(2963.64%↑ Y/Y)
Accrued expenses and
other liabilities
-$230K
(-90.08%↓ Y/Y)
Accounts payable
-$113K
(-28.41%↓ Y/Y)
Gain on sale of
equipment
$31K
Accretion of discount on
short-term investments
$4K
(-98.17%↓ Y/Y)
Back
Back
Cash Flow
CalciMedica, Inc. (CALC)
CalciMedica, Inc. (CALC)
source: myfinsight.com